Aimmune Therapeutics Inc AIMT:NASDAQ

Last Price$17.16Cboe Real-Time Last Sale as of 3:18PM ET 6/03/20
Cboe Real-Time Quotes
Realtime quote and/or trade prices are not sourced from all markets
Today's Change-0.36(2.05%)
Bid (Size)$17.17 (47)
Ask (Size)$17.22 (20)
Day Low / High$16.97 - 17.83
Volume578.7 K

Insider Trends: Insider Purchase Adds to Aimmune Therapeutics Positive Trend

5:05PM ET 3/19/2020 MT Newswires
Patrick G Enright, Director, on Mar 17, 2020, executed a purchase for 125,000 shares in Aimmune Therapeutics (AIMT) for $1,420,045. Enright has control over 6,183,695 shares of the company of which 70,561 shares are controlled directly and 6,113,134 shares indirectly following the transactions delineated in the Form 4 SEC filing. These holdings have an approximate market value of $71.2 million as of the prior-day closing price.

In the 90 days prior to the date of this filing, there have been 18 insider transactions reported to the SEC for Aimmune Therapeutics. These transactions came from the activities of 5 individual insiders that resulted in a net acquisition of 54,245 company shares. This compares with the preceding 90-day window of time where there were 2 transactions from 1 insider and resulted in no net change in insider holdings.

This level of insider transactions is lower than the peer group average in the 22-company Proprietary & Advanced Pharmaceuticals peer group over the last 90-day period. Activity in the peer group averaged 52.7 transactions per company, with company insiders acquiring on average 91,246 shares.

SEC Story Link